BioAtla, Inc. (BCAB) Misses Q2 EPS by 6c

BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• MaxCyte, Inc. (MXCT) Reports In-Line Q2 EPS
• Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23